VCCBH News


Whitaker Awarded $1.95M Grant to Unravel Anesthesia-Induced Hypotension

August 31, 2023 by Angela Ferrante

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics, received a substantial R35 MIRA grant from NIGMS for his study “Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age.” This five-year project—the department’s first NIH grant—addresses intraoperative hypotension in neonates, infants, and older adults under anesthesia.

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics at the Larner College of Medicine, has been granted a prestigious R35 MIRA award by the National Institute of General Medical Sciences (NIGMS) in recognition of his groundbreaking research on “Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age.” With an impressive grant of $1.95 million, equivalent to an R01, this funding will propel his investigations over the upcoming five years, focusing on understanding and mitigating intraoperative hypotension—an issue of critical concern among neonates, infants, and older adults undergoing anesthesia.

The unique feature of R35 grants lies in their provision of funding that isn’t confined to specific projects, affording researchers the flexibility to delve into emerging scientific ideas. Known as the Maximizing Investigators’ Research Award program (MIRA) within NIGMS, the R35 grant format has been in existence since 2015.

Whitaker’s research is poised to offer invaluable insights to medical professionals and anesthesiologists, empowering them to identify early intervention opportunities and determine the most efficacious approaches to enhance organ perfusion, transcending the sole emphasis on elevating blood pressure. Within the populations of neonates, infants, and geriatric patients, occurrences of intraoperative hypotension and compromised organ perfusion exceed the norm. While the precise mechanisms responsible for this distinction remain elusive, the pivotal role played by extreme age demographics is strongly inferred. The vascular systems of these diverse groups share several common attributes that may contribute to hypotension.

Whitaker and his dedicated team plan to synergize intact animal models with in vitro methods. This comprehensive approach enables scientists to study blood vessels both under typical conditions and in specific scenarios, facilitating a clear distinction between adjusted cases and controls. Notably, Whitaker emphasized that the factors contributing to this issue can exhibit considerable variability,

He elaborates, “Blood pressure interpretation can be intricate—it’s not an exact science. Optimal blood pressure may coexist with inadequate organ perfusion. Our focus is on comprehending and defining organ perfusion-based hypotension by monitoring blood flow in vital organs, such as the brain, kidneys, and gut. Subsequent induction of hypotension in test subjects enables us, as anesthesiologists, to ascertain the decline in organ blood flow. This knowledge equips us to intervene effectively, before irreversible organ damage occurs.”

Whitaker’s research seeks to evaluate the outcomes of potential interventions, assessing their impact on the target populations. Certain pressure agents, such as norepinephrine, may exhibit superior efficacy in treating anesthesia-induced hypotension compared to alternatives. Furthermore, the team aspires to uncover enhanced strategies for addressing organ perfusion beyond conventional blood pressure-centric treatments.

This research holds exceptional significance for the Larner College of Medicine, constituting a pivotal milestone—this is the first NIH grant awarded to the Department of Anesthesiology. “My colleagues in the department played a pivotal role,” emphasized Whitaker. “Their unwavering support was instrumental in not only laying the groundwork for this award but also in empowering me to achieve it.” This accomplishment highlights Whitaker’s expertise while also underscoring the institution’s dedication to advancing medical understanding and elevating patient care within the realm of anesthesiology.

“The folks at the Vermont Center for Cardiovascular and Brain Health (VCCBH), particularly Drs. Mary Cushman, Marilyn J. Cipolla, and Mark Nelson, played an integral role in securing this esteemed grant opportunity,” reflected Whitaker. “The VCCBH provides an immensely supportive environment. Grants of this caliber serve as crucial mechanisms for enhancing patient care and attracting diverse scientists, clinicians, and students keen on pioneering work in an environment that nurtures their pursuits.” Mary Cushman, M.D., along with Mark Nelson, Ph.D., are co-directors of the VCCBH and Marilyn Cipolla, Ph.D., is a professor of Neurological Sciences.



Recent Stories and Publications Featuring VCCBH Members


Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 23, 2024

In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research and assistant professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake” system, helping blood flow return to normal after neural activity.

The association of leptin and incident hypertension in the reasons for geographic and racial differences in stroke (REGARDS) cohort

Posted October 23, 2024

Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration.

Assessing prenatal and early childhood social and environmental determinants of health in the HEALthy Brain and Child Development Study (HBCD)

Posted October 23, 2024

The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood.

Health Watch: UVM researchers unlock secrets of brain blood flow in cognitive health

Posted October 16, 2024

Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it.

UVM at the Forefront of Stroke and Brain Health Research

Posted October 14, 2024

REGARDS Study Grant Renewed: UVM’s Continued Contributions to Research on Stroke Disparities by Race and Geography. Investigators at the Larner College of Medicine are receiving a $10.1 million multi-year grant from the National Institutes of Health (NIH) to continue their 23-year program studying stroke and cognitive disorders in the United States.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 2, 2024

Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those in some U.S. regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted August 21, 2024

Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5 at Magdalen College in Oxford, United Kingdom.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 31, 2024

A collaborative research team co-led by investigators David Jangraw, Ph.D., M.S., and Denise Peters, Ph.D., D.P.T., PT, has been awarded the 2024 Armin Grams Memorial Research Award by the Center on Aging. 

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 10, 2024

Two Larner-affiliated researchers won their respective poster competitions at the Vermont Center for Cardiovascular and Brain Health symposium held June 6–7 at the University of Vermont’s Davis Center.

Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases

Posted May 15, 2024

John Salogiannis, Ph.D., assistant professor of molecular physiology and biophysics, and members of his lab team—Allison (Morrissey) Langley, lab technician and Ph.D. candidate in cellular, molecular, and biomedical sciences; Sarah Abeling-Wang, lab research technician; and Erinn Wagner, UVM undergraduate biology major—have their first preprint*: “Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases.” The team’s research is supported by an NIH Maximizing Investigators’ Research Award (MIRA or R35) for early-stage investigators.

The University of Vermont Center on Aging Newsletter

Posted May 2024

Katharine Cheung, M.D., Ph.D., M.Sc., interim director of the UVM Center on Aging, associate director for research, and assistant professor of medicine, and her mentee, medical student Susanna Schuler ’26, presented their research findings at the American Academy of Hospice and Palliative Medicine State of the Science meeting on March 23 in Phoenix, Arizona.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted March 6, 2024

A study by a nationwide collaborative group, including Larner scientists Mary Cushman, M.D., M.Sc., University of Vermont Distinguished Professor and co-director of the Vermont Center for Cardiovascular and Brain Health, Russell Tracy, Ph.D., University of Vermont Distinguished Professor and director of UVM’s Laboratory for Clinical Biochemistry Research, Margaret Doyle Ph.D., associate professor of Pathology and Laboratory Medicine and co-director of the Laboratory of Clinical Biochemistry, and Rebekah Boyle, M.S., was recently published in Nature Communications.

 

UVM Scientist Wins Chan Zuckerberg Initiative Grant to Tackle Neurodegenerative Diseases

Larner Scientist Seeks to Advance Neurodegeneration Research

February 22, 2024

Larner College of Medicine scientist Osama Harraz, Ph.D., M.Sc., and his colleague from the University of Maryland (UMD), Thomas Longden, Ph.D., are recipients of a prestigious Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network (NCDN).